Simplicity Wealth’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Simplicity Wealth's GILD Position: Q2 2026 in Review
Simplicity Wealth increased its Gilead Sciences (GILD) stake by 36% in Q2 2026, buying an estimated $371K and bringing the position to 10,730 shares worth $1.36M. The position accounts for 0.05% of the portfolio, ranked #356.
Simplicity Wealth first reported a position in GILD in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.6M in Q1 2024. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Simplicity Wealth held 10,730 shares of Gilead Sciences worth $1.36M as of Q2 2026.
- Simplicity Wealth bought 2,816 Gilead Sciences shares in Q2 2026, an estimated $371K.
- Gilead Sciences made up 0.05% of Simplicity Wealth's portfolio in Q2 2026, its #356 holding.
- Simplicity Wealth first reported a position in Gilead Sciences in Q1 2024 and has held it in 8 quarters since.
- Simplicity Wealth's Gilead Sciences position peaked at $1.6M in Q1 2024.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.